Liu, J., Sun, X., Cui, Q., Wu, Y., Chen, Y., Xing, R., Lai, W., Bai, X., Qian, J., Liu, Q., Han, H., Fu, L., Liu, Y. (2025). Chidamide with the methotrexate, ifosfamide, etoposide, doxorubicin liposomes, and dexamethasone (MIEDD) regimen improves efficacy and safety in newly diagnosed primary CNS T-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-5418